Erin Reynolds, APN Nurse Practitioner - Family Medicare: Medicare Enrolled Practice Location: 800 Broadview Village Square, Broadview, IL 60155 Phone: 708-731-5555 |
Mrs. Malgorzata Zagrodny, MSN, FNP-BC Nurse Practitioner - Family Medicare: Accepting Medicare Assignments Practice Location: 800 Broadview Village Sq, Broadview, IL 60155 Phone: 866-389-2727 |
Khrystyna Huzar, Nurse Practitioner - Family Medicare: Accepting Medicare Assignments Practice Location: 800 Broadview Village Sq, Broadview, IL 60155 Phone: 773-606-8092 |
Olga Saletska, APN,CNP Nurse Practitioner - Family Medicare: Accepting Medicare Assignments Practice Location: 800 Broadview Village Sq, Broadview, IL 60155 Phone: 866-389-2727 |
Kajal Pandya Vora, FNP-C Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 800 Broadview Village Sq, Broadview, IL 60155 Phone: 708-731-5555 |
Tiffany R Budzinski, APN Nurse Practitioner - Family Medicare: Accepting Medicare Assignments Practice Location: 800 Broadview Village Square, Broadview, IL 60155 Phone: 708-731-5556 |
Kimberly Dolores Serrano, FNP-BC Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 800 Broadview Village Sq, Broadview, IL 60155 Phone: 708-731-5555 |
News Archive
A new study investigates the persistence of neuropsychiatric symptoms in children and adolescents several months after they tested positive for SARS-CoV-2.
Research led by Hernan A. Bazan, MD, Assistant Professor of Surgery, Section of Vascular Surgery, at LSU Health Sciences Center New Orleans School of Medicine, has found that unstable carotid artery plaques - those in danger of rupturing and leading to a stroke - contain more inflammation and significantly less omega-3 fatty acids than asymptomatic plaques.
Thousands of women die from breast cancer each year because current treatments are not always effective and in some cases fail to stem the disease, warns Breast Cancer Campaign today.
Diabetes, which now affects almost 30 million Americans, can cause serious health complications, including heart disease, blindness, kidney failure and lower-extremity amputations.
Alnylam Pharmaceuticals, Inc., a leading RNAi therapeutics company, announced today that it presented new pre-clinical research findings from its transthyretin (TTR)-mediated amyloidosis (ATTR) program at the 60th Annual Meeting of the American Association for the Study of Liver Diseases ("The Liver Meeting").
› Verified 9 days ago